Pursuing paradoxical proconvulsant prophylaxis for epileptogenesis.
Ontology highlight
ABSTRACT: There are essentially two potential treatment options for any acquired disorder: symptomatic or prophylactic. For acquired epilepsies that follow a variety of different brain insults, there remains a complete lack of prophylactic treatment options, whereas at the same time these epilepsies are notoriously resistant, once they have emerged, to symptomatic treatments with antiepileptic drugs. The development of prophylactic strategies is logistically challenging, both for basic researchers and clinicians. Nevertheless, cannabinoid-targeting drugs provide a very interesting example of a system within the central nervous system (CNS) that can have very different acute and long-term effects on hyperexcitability and seizures. In this review, we outline research on cannabinoids suggesting that al
SUBMITTER: Armstrong C
PROVIDER: S-EPMC2894282 | biostudies-literature | 2009 Jul
REPOSITORIES: biostudies-literature
ACCESS DATA